Suppr超能文献

2 型糖尿病患者体成分测量的基线和纵向变化与心力衰竭和心肌梗死风险的关联:来自 LOOK AHEAD 试验的结果。

Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.

机构信息

Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (K.V.P., J.D.B., A.P.).

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (K.V.P.).

出版信息

Circulation. 2020 Dec 22;142(25):2420-2430. doi: 10.1161/CIRCULATIONAHA.120.050941. Epub 2020 Nov 9.

Abstract

BACKGROUND

Intentional weight loss is associated with lower risk of heart failure (HF) and atherosclerotic cardiovascular disease among patients with type 2 diabetes. However, the contribution of baseline measures and longitudinal changes in fat mass (FM), lean mass (LM), and waist circumference (WC) to the risk of HF and myocardial infarction (MI) in type 2 diabetes is not well established.

METHODS

Adults from the Look AHEAD trial (Action for Health in Diabetes) without prevalent HF were included. FM and LM were predicted using validated equations and compared with dual-energy x-ray absorptiometry measurements in a subgroup. Adjusted Cox models were used to evaluate the associations of baseline and longitudinal changes in FM, LM, and WC over 1- and 4-year follow-up with risk of overall HF, HF with preserved ejection fraction (EF; EF ≥50%), HF with reduced EF (EF <50%), and MI.

RESULTS

Among 5103 participants, there were 257 incident HF events over 12.4 years of follow-up. Predicted and measured FM/LM were highly correlated (=0.87-0.90; n=1369). FM and LM decreased over 4-year follow-up with greater declines in the intensive lifestyle intervention arm. In adjusted analysis, baseline body composition measures were not significantly associated with HF risk. Decline in FM and WC, but not LM, over 1 year were each significantly associated with lower risk of overall HF (adjusted hazard ratio per 10% decrease in FM, 0.80 [95% CI, 0.68-0.95]; adjusted hazard ratio per 10% decrease in WC, 0.77 [95% CI, 0.62-0.95]). Decline in FM was significantly associated with lower risk of both HF subtypes. In contrast, decline in WC was significantly associated with lower risk of HF with preserved EF but not HF with reduced EF. Similar patterns of association were observed for 4-year changes in body composition and HF risk. Longitudinal changes in body composition were not significantly associated with risk of MI.

CONCLUSIONS

In adults with type 2 diabetes, a lifestyle intervention is associated with significant loss of FM and LM. Declines in FM and WC, but not LM, were each significantly associated with lower risk of HF but not MI. Furthermore, decline in WC was significantly associated with lower risk of HF with preserved EF but not HF with reduced EF. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00017953.

摘要

背景

在 2 型糖尿病患者中,有目的的减肥与心力衰竭(HF)和动脉粥样硬化性心血管疾病风险降低有关。然而,基线测量值和脂肪量(FM)、瘦体重(LM)和腰围(WC)的纵向变化对 2 型糖尿病 HF 和心肌梗死(MI)风险的贡献尚不清楚。

方法

纳入来自 LOOK AHEAD 试验(糖尿病中的健康行动)且无HF 既往史的成年人。使用经过验证的方程预测 FM 和 LM,并在亚组中与双能 X 射线吸收法测量值进行比较。使用调整后的 Cox 模型评估 1 年和 4 年随访期间 FM、LM 和 WC 的基线和纵向变化与整体 HF、射血分数保留的 HF(EF≥50%)、射血分数降低的 HF(EF<50%)和 MI 风险的相关性。

结果

在 5103 名参与者中,有 257 例 HF 事件发生在 12.4 年的随访期间。预测的和测量的 FM/LM 具有高度相关性(=0.87-0.90;n=1369)。在 4 年的随访中,FM 和 LM 逐渐减少,强化生活方式干预组的下降幅度更大。在调整分析中,基线身体成分测量值与 HF 风险无显著相关性。1 年内 FM 和 WC 的下降与整体 HF 风险降低显著相关(FM 每降低 10%,调整后的危险比为 0.80[95%CI,0.68-0.95];WC 每降低 10%,调整后的危险比为 0.77[95%CI,0.62-0.95])。FM 的下降与两种 HF 亚型的风险降低均显著相关。相比之下,WC 的下降与射血分数保留的 HF 风险降低显著相关,但与射血分数降低的 HF 风险降低无关。身体成分的 4 年变化与 HF 风险的关联模式相似。身体成分的纵向变化与 MI 风险无显著相关性。

结论

在 2 型糖尿病成人中,生活方式干预与 FM 和 LM 的显著丢失有关。FM 和 WC 的下降(但不是 LM)与 HF 风险降低显著相关,但与 MI 风险无关。此外,WC 的下降与射血分数保留的 HF 风险降低显著相关,但与射血分数降低的 HF 风险降低无关。

登记

网址:https://www.clinicaltrials.gov;唯一标识符:NCT00017953。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470c/8366747/01fad8274c24/nihms-1638058-f0001.jpg

相似文献

7
Change in body composition during a weight loss trial in obese adolescents.肥胖青少年减肥试验期间身体成分的变化。
Pediatr Obes. 2014 Feb;9(1):26-35. doi: 10.1111/j.2047-6310.2012.00139.x. Epub 2013 Feb 5.
8
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.达格列净对 2 型糖尿病心力衰竭和死亡的影响。
Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18.

引用本文的文献

1
The Impact of Obesity on Cardiovascular Diseases: Heart Failure.肥胖对心血管疾病的影响:心力衰竭
Methodist Debakey Cardiovasc J. 2025 Feb 18;21(2):44-52. doi: 10.14797/mdcvj.1511. eCollection 2025.
10
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.体脂损耗:治疗 2 型糖尿病的阴性质地疗法。
Curr Atheroscler Rep. 2024 Jan;26(1):1-10. doi: 10.1007/s11883-023-01181-4. Epub 2023 Dec 27.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验